Draxxin – New From Pfizer Animal Health

Chuck Zimmerman

Draxxin Injectable SolutionI recently received the media kit for the Draxxin Injectable Solution annoucement from Pfizer Animal Health. Besides letting you know about it I thought I’d comment on the “kit.” I think it’s nice to receive a very easy to use and functional media kit like this. Basically it came with a nice explanatory cover letter from the agency (Rhea & Kaiser) and a CD which contains the news release, photos, logo, faq’s, research reports on the product, the label and contacts for more information. Very creatively done, excellent graphic work, the disk worked and was easy to use.

Draxxin Media KitSince this is a new product launch it’s obvious that more budget was put into the announcement by providing us with this quality of materials. It was mailed the good old fashioned way. Another approach would have been to have it created on the company website and I could have been emailed a link to it in a release. This would have prompted me to look at it sooner. I confess to letting this sit on my desk for a week or so before loading the disk into my computer. (I’m not lazy just using every second that’s available!)

I have to say that audio would have been handy. With a CD it would be easy to have some interviews recorded and placed on the disk for us podcasters or broadcasters or how about those print folks who have broadcast or web based audio content now? Gimme some sound! Maybe even a little video?

I like the name. Kind of reminds me of Hugo Drax for all you James Bond fans.

Pfizer Animal Health Introduces DRAXXIN™ (tulathromycin) Injectable Solution – New, single-dose antibacterial provides superior treatment for bovine respiratory disease

NEW YORK – A new, single-dose antibacterial that provides more effective treatment of bovine respiratory disease (BRD) has been developed by Pfizer Animal Health. Clinical studies and field trials demonstrate that new DRAXXIN is highly efficacious for treating naturally occurring respiratory disease in cattle. 1

“Our goal in developing DRAXXIN was to set a new standard of effectiveness for treatment of costly livestock diseases,” said Ann Jernigan, DVM, PhD, vice president, Veterinary Medicine Research and Development, Pfizer Animal Health.

DRAXXIN is indicated for treatment of BRD and control of respiratory disease in cattle at high risk of developing BRD caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni(Haemophilus somnus).

For more information contact Dave Harding.

Agencies, Agribusiness